Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000633840 | SCV000755113 | uncertain significance | Gastrointestinal stromal tumor | 2023-07-19 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 528618). This variant has not been reported in the literature in individuals affected with PDGFRA-related conditions. This variant is present in population databases (rs139217250, gnomAD 0.004%). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 176 of the PDGFRA protein (p.Gln176Arg). |
Ambry Genetics | RCV001023851 | SCV001185783 | likely benign | Hereditary cancer-predisposing syndrome | 2024-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Baylor Genetics | RCV003471987 | SCV004200915 | uncertain significance | Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal | 2023-09-06 | criteria provided, single submitter | clinical testing |